查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1842244

美国兽医眼科市场：市场规模、份额和趋势分析（按动物、产品、适应症和分销管道划分），细分市场预测（2025-2033 年）

U.S. Veterinary Eye Care Market Size, Share & Trends Analysis Report By Animal (Canine, Feline, Equine, Bovine), By Product (Devices & Instruments, Medications), By Indication, By Distribution Channel, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

美国兽医眼科市场概览

据估计，2024 年美国兽医眼科市值为 16.6 亿美元，预计到 2033 年将达到 27.1 亿美元，2025 年至 2033 年的复合年增长率为 5.6%。

推动这一市场发展的因素包括动物眼科护理途径的扩展、对合理使用抗生素的日益倡导、兽医专业人员更多地参与宣传推广以及动物眼科护理技术的进步。

在美国，兽医眼科领域正经历显着成长，这得益于外科技术、基因研究和诊断技术的进步。这些发展正在扩大兽医眼科的诊疗范围，并为曾经被认为无法治癒的疾病带来新的希望。

一个值得注意的例子是，2025年1月在加州大学戴维斯分校进行的一项手术，该手术采用视网膜復位术（视网膜固定术）治疗犬类视网膜裂孔。手术方法是将眼内的天然凝胶替换为硅油，从而将视网膜復位，有效恢復患者的视力。由于手术设备和培训的改进，这种专业手术正变得越来越普及。

基因研究在兽医眼科学中也扮演着至关重要的角色。例如，dvm360 于 2025 年 3 月发表的一项研究已经确定了导致犬隻进行性视网膜萎缩 (PRA) 等疾病的特定基因突变。例如，GTPBP2 基因中三个碱基对的缺失与 PRA 相关，这为基因检测和基于基因的育种决策提供了基础。这种方法旨在防止此类疾病的遗传，从而降低其在后代中的盛行率。

就治疗方案而言，拉坦前列素在猫青光眼治疗的应用凸显了兽医眼科学的复杂性。虽然拉坦前列素能有效降低猫的眼内压，但其局限性也表明，需要继续研究和开发更适合猫生理特征的更有效的治疗方法。

此外，采用雷射技术治疗犬类眼睑肿瘤代表非侵入性外科技术的重大进步。根据dvm360网站2025年3月发表的一篇报导报道，与传统方法相比，雷射治疗具有更高的精准度和更快的恢復速度，从而改善了宠物和饲主的整体治疗体验。

这些以及其他创新推动了兽医眼科学领域的蓬勃发展和快速进步。随着该领域的不断进步，预计它将反映出兽医护理专业化、人性化这一更广泛的趋势，并改善患有各种眼科疾病的动物的治疗效果。

目录

第一章 分析方法和范围

第二章执行摘要

第三章美国动物眼科市场：驱动因素、趋势与范围

  • 市场关联性展望
    • 母市场
    • 附随市场
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
    • 市场机会分析
    • 市场问题分析
    • 产业分析
    • 定价分析
    • 主要品种动物数量估算（2021-2024 年）

第四章：美国动物眼科市场：依动物类型分類的估算与趋势分析

  • 细分仪表板
  • 美国兽医眼科市场：按物种分類的变化分析
  • 美国兽医眼科市场规模及趋势分析（按物种划分）（2021-2033 年）
  • 犬齿
  • 猫科动物
  • 马
  • 牛
  • 其他动物

第五章：美国动物眼科市场：依产品分類的估算与趋势分析

  • 细分仪表板
  • 美国兽医眼科市场：按产品分類的变化分析
  • 美国兽医眼科市场规模及产品趋势分析（2021-2033）
  • 设备和器材
  • 治疗设备
  • 製药
    • 2021-2033年医药产业收入估算与预测
    • 抗生素
    • NSAID
    • 皮质类固醇
    • 润滑剂/人工泪液
    • 止痛药
    • 其他药物

第六章：美国动物眼科市场：依适应症分類的估算与趋势分析

  • 细分仪表板
  • 美国兽医眼科市场：依适应症分類的变化分析
  • 美国兽医眼科市场规模及趋势分析（依适应症划分）（2021-2033 年）
    • 眼睑异常
    • 白内障
    • 青光眼
    • 葡萄膜炎
    • 结膜炎
    • 角膜併发症
    • 其他迹象

第七章：美国动物眼科市场：按分销管道分類的估算和趋势分析

  • 细分仪表板
  • 美国兽医眼科市场：按通路分類的变化分析
  • 美国兽医眼科市场规模及趋势分析（按分销管道划分）（2021-2033 年）
    • 兽医医院和诊所
    • 专卖店
    • 电子商务
    • 其他分销管道

第八章 竞争情势

  • 市场参与企业分类
  • 企业市场分析/热力图分析
  • 公司简介
    • Merck &Co., Inc.
    • An-Vision GmbH
    • Jorgensen Laboratories
    • LKC Technologies Inc.
    • Accutome Inc.
    • Dechra
    • Bausch &Lomb Incorporated
    • Zoetis Services LLC.
    • Ceva Sante Animale
    • Sandoz
    • Boehringer Ingelheim
    • I-Med Animal Health
    • Iridex Corporation
    • Baxter（Welch Allyn）
    • OptoMed
    • Reichert, Inc.
    • Occuity
    • Strategy Mapping
    • Mergers &Acquisitions
    • Partnerships &Collaborations
    • Product launch
    • Others
  • 其他主要企业名单
Product Code: GVR-4-68040-724-2

U.S. Veterinary Eye Care Market Summary

The U.S. veterinary eye care market size was estimated at USD 1.66 billion in 2024 and is projected to reach USD 2.71 billion by 2033, growing at a CAGR of 5.6% from 2025 to 2033. The market is advancing owing to factors such as expanding veterinary eye care avenues, increasing advocacy for rationale use of antibiotics, growing involvement of veterinary professionals in spreading awareness, and technological advancements in veterinary eye care.

The veterinary eye care sector in the U.S. is experiencing significant growth, driven by advancements in surgical techniques, genetic research, and diagnostic technologies. These developments are expanding the scope of eye care for animals, offering new hope for conditions that were once considered untreatable.

A notable example is the use of retinal reattachment surgery, or retinopexy, conducted in January 2025, by UC Davis, to address retinal tears in dogs. This procedure involves replacing the natural gel in the eye with silicone oil to reposition the retina, effectively restoring vision in affected animals. Such specialized surgeries are becoming more accessible, thanks to improvements in surgical equipment and training.

Genetic research is also playing a pivotal role in veterinary eye care. Studies such as the March 2025 article published by dvm360 have identified specific genetic mutations responsible for conditions such as progressive retinal atrophy (PRA) in dogs. For instance, a 3-base pair deletion in the GTPBP2 gene has been linked to PRA, providing a basis for genetic testing and informed breeding decisions. This approach aims to prevent the hereditary transmission of such conditions, thereby reducing their prevalence in future generations.

In terms of treatment options, the use of latanoprost in managing glaucoma in cats highlights the complexities of veterinary ophthalmology. While latanoprost has shown efficacy in lowering intraocular pressure in cats, its limitations underscore the need for ongoing research and development of more effective therapies tailored to feline physiology.

Furthermore, the adoption of laser technology for treating canine eyelid tumors represents a significant advancement in non-invasive surgical techniques. As per March 2025 article published by dvm360, laser treatments offer precision and reduced recovery times compared to traditional methods, enhancing the overall treatment experience for both pets and their owners.

Collectively, these innovations are contributing to a dynamic and rapidly evolving veterinary ophthalmology landscape. As the field continues to progress, it holds the promise of improved outcomes for animals suffering from a range of ocular conditions, reflecting a broader trend toward specialized and compassionate veterinary care.

U.S. Veterinary Eye Care Market Report Segmentation

This report forecasts revenue growth at country level and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. veterinary eye care market report based on animal, product, indication, and distribution channel:

  • Animal Outlook (Revenue, USD Million, 2021 - 2033)
  • Canine
  • Feline
  • Equine
  • Bovine
  • Others
  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Devices & Instruments
    • Diagnostic Devices
    • Tonometers
    • Ophthalmic Test Kits
    • Electroretinogram (ERG)
    • Fundus Camera
    • Ophthalmoscopes
    • Pachymeter
    • Other Diagnostic Devices
    • Treatment Devices
    • Lenses
    • Bandage Lenses
    • Intraocular Lenses
    • Laser Devices
    • Other Treatment Devices
  • Medications
    • Antibiotics
    • NSAIDs
    • Corticosteroids
    • Lubricants / Artificial Tears
    • Analgesics / Pain Relievers
    • Other Medications
  • Indication Outlook (Revenue, USD Million, 2021 - 2033)
  • Eyelid Abnormalities
  • Cataract
  • Glaucoma
  • Retinal Complications
  • Uveitis
  • Conjunctivitis
  • Corneal Complications
  • Other Indications
  • Distribution Channel Outlook (Revenue, USD Million, 2021 - 2033)
  • Veterinary Hospitals & Clinics
  • Specialty Stores
  • E-Commerce
  • Other Distribution Channels

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased Database
    • 1.3.2. GVR's Internal Database
    • 1.3.3. Secondary Sources
    • 1.3.4. Primary Research
  • 1.4. Information/Data Analysis
  • 1.5. Market Formulation & Visualization
  • 1.6. Data Validation & Publishing
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis
    • 1.7.2. Country Market: CAGR Calculation
  • 1.8. List of Secondary Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. U.S. Veterinary Eye Care Market Variable Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market
    • 3.1.2. Ancillary Market
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Expanding Veterinary Eye Care Avenues
      • 3.2.1.2. Increasing Advocacy for Rationale Use of Antibiotics
      • 3.2.1.3. Growing Involvement of Veterinary Professionals in Spreading Awareness
      • 3.2.1.4. Technological Advancements in Veterinary Eye Care
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. High Cost Of Veterinary Ophthalmic Procedures
      • 3.2.2.2. Limitations of Medications in Ophthalmology Care
    • 3.2.3. Market Opportunity Analysis
    • 3.2.4. Market Challenge Analysis
    • 3.2.5. Industry Analysis
      • 3.2.5.1. Porter's Five Forces Analysis
      • 3.2.5.2. PESTLE by SWOT Analysis
    • 3.2.6. Pricing Analysis
    • 3.2.7. Estimated Animal Population by key species, 2021 - 2024

Chapter 4. U.S. Veterinary Eye Care Market: Animal Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. U.S. Veterinary Eye Care Market: Animal Movement Analysis
  • 4.3. U.S. Veterinary Eye Care Market Size & Trend Analysis, by animal, 2021 to 2033 (USD Million)
  • 4.4. Canine
    • 4.4.1. Canine Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.5. Feline
    • 4.5.1. Feline Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.6. Equine
    • 4.6.1. Equine Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.7. Bovine
    • 4.7.1. Bovine Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.8. Other Animals
    • 4.8.1. Other Animals Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. U.S. Veterinary Eye Care Market: Product Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. U.S. Veterinary Eye Care Market: Product Movement Analysis
  • 5.3. U.S. Veterinary Eye Care Market Size & Trend Analysis, by Product, 2021 to 2033 (USD Million)
  • 5.4. Devices & Instruments
    • 5.4.1. Devices & Instruments Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 5.4.1.1. Diagnostic Devices
        • 5.4.1.1.1. Diagnostic Devices Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 5.4.1.2. Tonometers
        • 5.4.1.2.1. Tonometers Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 5.4.1.3. Ophthalmic Test Kits
        • 5.4.1.3.1. Ophthalmic Test Kits Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 5.4.1.4. Electroretinogram (ERG)
        • 5.4.1.4.1. Electroretinogram (ERG) Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 5.4.1.5. Fundus Camera
        • 5.4.1.5.1. Fundus Camera Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 5.4.1.6. Ophthalmoscopes
        • 5.4.1.6.1. Ophthalmoscopes Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 5.4.1.7. Pachymeter
        • 5.4.1.7.1. Pachymeter Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 5.4.1.8. Other Diagnostic Devices
        • 5.4.1.8.1. Other Diagnostic Devices Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.5. Treatment Devices
    • 5.5.1. Treatment Devices Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 5.5.1.1. Lenses
        • 5.5.1.1.1. Lenses Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
        • 5.5.1.1.2. Bandage Lenses
          • 5.5.1.1.2.1. Bandage Lenses Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
        • 5.5.1.1.3. Intraocular Lenses
          • 5.5.1.1.3.1. Intraocular Lenses Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 5.5.1.2. Laser Devices
        • 5.5.1.2.1. Laser Devices Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 5.5.1.3. Other Treatment Devices
        • 5.5.1.3.1. Other Treatment Devices Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.6. Medications
    • 5.6.1. Medications Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.6.2. Antibiotics
      • 5.6.2.1. Antibiotics Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.6.3. NSAIDs
      • 5.6.3.1. NSAIDs Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.6.4. Corticosteroids
      • 5.6.4.1. Corticosteroids Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.6.5. Lubricants / Artificial Tears
      • 5.6.5.1. Lubricants / Artificial Tears Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.6.6. Analgesics / Pain Relievers
      • 5.6.6.1. Analgesics / Pain Relievers Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.6.7. Other Medications
      • 5.6.7.1. Other Medications Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. U.S. Veterinary Eye Care Market: By Indication Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. U.S. Veterinary Eye Care Market: By Indication Movement Analysis
  • 6.3. U.S. Veterinary Eye Care Market Size & Trend Analysis, by Indication, 2021 to 2033 (USD Million)
    • 6.3.1. Eyelid Abnormalities
      • 6.3.1.1. Eyelid Abnormalities Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.3.2. Cataract
      • 6.3.2.1. Cataract Care Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.3.3. Glaucoma
      • 6.3.3.1. Glaucoma Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 6.3.3.2. Retinal Complications
      • 6.3.3.3. Retinal Complications Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.3.4. Uveitis
      • 6.3.4.1. Uveitis Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.3.5. Conjunctivitis
      • 6.3.5.1. Conjunctivitis Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.3.6. Corneal Complications
      • 6.3.6.1. Corneal Complications Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.3.7. Other Indications
      • 6.3.7.1. Other Indications Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. U.S. Veterinary Eye Care Market: By Distribution Channel Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. U.S. Veterinary Eye Care Market: By Distribution Channel Movement Analysis
  • 7.3. U.S. Veterinary Eye Care Market Size & Trend Analysis, by Distribution Channel, 2021 to 2033 (USD Million)
    • 7.3.1. Veterinary Hospitals & Clinics
      • 7.3.1.1. Veterinary Hospitals & Clinics Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.3.2. Specialty Stores
      • 7.3.2.1. Specialty Stores Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.3.3. E-Commerce
      • 7.3.3.1. E-Commerce Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.3.4. Other Distribution Channels
      • 7.3.4.1. Other Distribution Channels Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Market Participant Categorization
  • 8.2. Company Market Position Analysis/ Heat Map Analysis
  • 8.3. Company Profiles
    • 8.3.1. Merck & Co., Inc.
      • 8.3.1.1. Participant's Overview
      • 8.3.1.2. Financial Performance
      • 8.3.1.3. Product Benchmarking
      • 8.3.1.4. Strategic Initiatives
    • 8.3.2. An-Vision GmbH
      • 8.3.2.1. Participant's Overview
      • 8.3.2.2. Financial Performance
      • 8.3.2.3. Product Benchmarking
      • 8.3.2.4. Strategic Initiatives
    • 8.3.3. Jorgensen Laboratories
      • 8.3.3.1. Participant's Overview
      • 8.3.3.2. Financial Performance
      • 8.3.3.3. Product Benchmarking
      • 8.3.3.4. Strategic Initiatives
    • 8.3.4. LKC Technologies Inc.
      • 8.3.4.1. Participant's Overview
      • 8.3.4.2. Financial Performance
      • 8.3.4.3. Product Benchmarking
      • 8.3.4.4. Strategic Initiatives
    • 8.3.5. Accutome Inc.
      • 8.3.5.1. Participant's Overview
      • 8.3.5.2. Financial Performance
      • 8.3.5.3. Product Benchmarking
      • 8.3.5.4. Strategic Initiatives
    • 8.3.6. Dechra
      • 8.3.6.1. Participant's Overview
      • 8.3.6.2. Financial Performance
      • 8.3.6.3. Product Benchmarking
      • 8.3.6.4. Strategic Initiatives
    • 8.3.7. Bausch & Lomb Incorporated
      • 8.3.7.1. Participant's Overview
      • 8.3.7.2. Financial Performance
      • 8.3.7.3. Product Benchmarking
      • 8.3.7.4. Strategic Initiatives
    • 8.3.8. Zoetis Services LLC.
      • 8.3.8.1. Participant's Overview
      • 8.3.8.2. Financial Performance
      • 8.3.8.3. Product Benchmarking
      • 8.3.8.4. Strategic Initiatives
    • 8.3.9. Ceva Sante Animale
      • 8.3.9.1. Participant's Overview
      • 8.3.9.2. Financial Performance
      • 8.3.9.3. Product Benchmarking
      • 8.3.9.4. Strategic Initiatives
    • 8.3.10. Sandoz
      • 8.3.10.1. Participant's Overview
      • 8.3.10.2. Financial Performance
      • 8.3.10.3. Product Benchmarking
      • 8.3.10.4. Strategic Initiatives
    • 8.3.11. Boehringer Ingelheim
      • 8.3.11.1. Participant's Overview
      • 8.3.11.2. Financial Performance
      • 8.3.11.3. Product Benchmarking
      • 8.3.11.4. Strategic Initiatives
    • 8.3.12. I-Med Animal Health
      • 8.3.12.1. Participant's Overview
      • 8.3.12.2. Financial Performance
      • 8.3.12.3. Product Benchmarking
      • 8.3.12.4. Strategic Initiatives
    • 8.3.13. Iridex Corporation
      • 8.3.13.1. Participant's Overview
      • 8.3.13.2. Financial Performance
      • 8.3.13.3. Product Benchmarking
      • 8.3.13.4. Strategic Initiatives
    • 8.3.14. Baxter (Welch Allyn)
      • 8.3.14.1. Participant's Overview
      • 8.3.14.2. Financial Performance
      • 8.3.14.3. Product Benchmarking
      • 8.3.14.4. Strategic Initiatives
    • 8.3.15. OptoMed
      • 8.3.15.1. Participant's Overview
      • 8.3.15.2. Financial Performance
      • 8.3.15.3. Product Benchmarking
      • 8.3.15.4. Strategic Initiatives
    • 8.3.16. Reichert, Inc.
      • 8.3.16.1. Participant's Overview
      • 8.3.16.2. Financial Performance
      • 8.3.16.3. Product Benchmarking
      • 8.3.16.4. Strategic Initiatives
    • 8.3.17. Occuity
      • 8.3.17.1. Participant's Overview
      • 8.3.17.2. Financial Performance
      • 8.3.17.3. Product Benchmarking
      • 8.3.17.4. Strategic Initiatives
    • 8.3.18. Strategy Mapping
    • 8.3.19. Mergers & Acquisitions
    • 8.3.20. Partnerships & Collaborations
    • 8.3.21. Product launch
    • 8.3.22. Others
  • 8.4. List of other key players

List of Tables

  • Table 1 List of secondary sources
  • Table 2 U.S. Veterinary Eye Care Market, by Animal, 2021 - 2033 (USD Million)
  • Table 3 U.S. Veterinary Eye Care Market, by Product, 2021 - 2033 (USD Million)
  • Table 4 U.S. Veterinary Eye Care Market, by Indication, 2021 - 2033 (USD Million)
  • Table 5 U.S. Veterinary Eye Care Market, by Distribution Channel, 2021 - 2033 (USD Million)
  • Table 6 Company Overview
  • Table 7 Product Benchmarking
  • Table 8 Financial Performance
  • Table 9 Strategic Initiatives

List of Figures

  • Fig. 1 Market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value chain-based sizing & forecasting
  • Fig. 7 QFD modelling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 U.S. Veterinary Eye Care Market revenue, 2021 - 2033 (USD Million)
  • Fig. 10 U.S. Veterinary Eye Care Market snapshot
  • Fig. 11 U.S. Veterinary Eye Care Market driver impact
  • Fig. 12 U.S. Veterinary Eye Care Market restraint impact
  • Fig. 13 Veterinary Eye Care animal key takeaways (USD Million)
  • Fig. 14 U.S. Veterinary Eye Care Market: animal, market share 2024 & 2033
  • Fig. 15 Canine market, 2021 - 2033 (USD Million)
  • Fig. 16 Feline market, 2021 - 2033 (USD Million)
  • Fig. 17 Equine market, 2021 - 2033 (USD Million)
  • Fig. 18 Bovine market, 2021 - 2033 (USD Million)
  • Fig. 19 Other Animals market, 2021 - 2033 (USD Million)
  • Fig. 20 U.S. Veterinary Eye Care Market Product key takeaways (USD Million)
  • Fig. 21 U.S. Veterinary Eye Care Market: Product, market share 2024 & 2033
  • Fig. 22 Devices & Instruments market, 2021 - 2033 (USD Million)
  • Fig. 23 Diagnostic Devices market, 2021 - 2033 (USD Million)
  • Fig. 24 Tonometers market, 2021 - 2033 (USD Million)
  • Fig. 25 Ophthalmic Test Kits market, 2021 - 2033 (USD Million)
  • Fig. 26 Electroretinogram (ERG) market, 2021 - 2033 (USD Million)
  • Fig. 27 Fundus Camera market, 2021 - 2033 (USD Million)
  • Fig. 28 Ophthalmoscopes market, 2021 - 2033 (USD Million)
  • Fig. 29 Pachymeter market, 2021 - 2033 (USD Million)
  • Fig. 30 Other Diagnostic Devices market, 2021 - 2033 (USD Million)
  • Fig. 31 Treatment Devices market, 2021 - 2033 (USD Million)
  • Fig. 32 Lenses market, 2021 - 2033 (USD Million)
  • Fig. 33 Bandage Lenses market, 2021 - 2033 (USD Million)
  • Fig. 34 Intraocular Lenses market, 2021 - 2033 (USD Million)
  • Fig. 35 Laser Devices market, 2021 - 2033 (USD Million)
  • Fig. 36 Other Treatment Devices market, 2021 - 2033 (USD Million)
  • Fig. 37 Medications market, 2021 - 2033 (USD Million)
  • Fig. 38 Antibiotics market, 2021 - 2033 (USD Million)
  • Fig. 39 NSAIDs market, 2021 - 2033 (USD Million)
  • Fig. 40 Corticosteroids market, 2021 - 2033 (USD Million)
  • Fig. 41 Lubricants / Artificial Tears market, 2021 - 2033 (USD Million)
  • Fig. 42 Analgesics / Pain Relievers market, 2021 - 2033 (USD Million)
  • Fig. 43 Other Medications market, 2021 - 2033 (USD Million)
  • Fig. 44 Veterinary Eye Care market by Indication: Key takeaways
  • Fig. 45 Veterinary Eye Care market by Indication, market share, 2024 & 2033
  • Fig. 46 Eyelid Abnormalities market, 2021 - 2033 (USD Million)
  • Fig. 47 Cataract market, 2021 - 2033 (USD Million)
  • Fig. 48 Glaucoma market, 2021 - 2033 (USD Million)
  • Fig. 49 Retinal Complications market, 2021 - 2033 (USD Million)
  • Fig. 50 Uveitis market, 2021 - 2033 (USD Million)
  • Fig. 51 Conjunctivitis market, 2021 - 2033 (USD Million)
  • Fig. 52 Corneal Complications market, 2021 - 2033 (USD Million)
  • Fig. 53 Other Indications market, 2021 - 2033 (USD Million)
  • Fig. 54 Veterinary Eye Care market by Distribution Channel: Key takeaways
  • Fig. 55 Veterinary Eye Care market by Distribution Channel, market share, 2024 & 2033
  • Fig. 56 Veterinary Hospitals & Clinics market, 2021 - 2033 (USD Million)
  • Fig. 57 Specialty Stores market, 2021 - 2033 (USD Million)
  • Fig. 58 E-Commerce market, 2021 - 2033 (USD Million)
  • Fig. 59 Other Distribution Channels market, 2021 - 2033 (USD Million)
  • Fig. 60 Market participant categorization